Capital Health Will be First in U.S. to Offer GE Molecular Breast Imaging

GE Healthcare’s Discovery NM 750b Is a Specialized Breast Scanner That Enables Advanced Functional Imaging of Breast Cancer

HOPEWELL TOWNSHIP, N.J. & WAUKESHA, Wis.--(BUSINESS WIRE)-- Capital Health and GE Healthcare announced today the first Discovery* NM 750b was installed at Capital Health’s New Jersey Hopewell medical center. Capital Health is a central New Jersey region leader in advanced medicine, with significant investments in advanced technologies and its medical staff.

“We are very pleased to offer women in our community this new, highly sophisticated, test that can help detect breast cancer at its earliest stages, which, as we all know, can be critical to the success of treatment,” said Al Maghazehe, president and CEO of Capital Health. “We remain committed to bringing patients in this region the latest technological advances to enhance their healthcare options.”

“This innovative technology overcomes some of the challenges we currently face with breast cancer detection, particularly in women with dense breast tissue, and allows us to offer our patients improved medical care,” said Dr. Yaakov Applbaum, medical director of the Radiology Department at Capital Health. “It will also be useful in the early detection of breast cancer in women who are at a high risk for the disease.”

Breast cancer detection is sometimes difficult, as breast density in varying degrees can overlap with lesions, making them harder to find with traditional x-ray mammography; and interpretation can vary among physicians, which can often lead to recommendations for additional tests.

Molecular Breast Imaging, or MBI, is less susceptible to breast density, since the method involves a radioactive tracer that has a high affinity for metabolically active tumors, and two specialized detectors imaging the breast from opposing angles. MBI has been shown in clinical studies to outperform mammography for early detection, and in finding more cancers.1

The GE Discovery NM 750b scanner features dual detectors with CZT technology. The system’s innovative detector design facilitates increased imaging sensitivity compared to conventional Nuclear Medicine “Gamma” cameras. In addition, image contrast and quality represent significant improvements over conventional systems. Imaging of the breast can be performed with only light immobilization and without the need of full compression. The Discovery NM 750b is intended to become part of a comprehensive arsenal of advanced imaging technologies that includes PET (Positron Emission Tomography), Spiral CT and MRI (Magnetic Resonance Imaging).

“We believe that offering MBI with its ability to detect certain cases of breast cancer earlier will make Capital Health the premier destination in the area for breast cancer diagnosis,” said Applbaum. “Molecular imaging is being added to the already comprehensively equipped Woman’s Imaging Center at Capital Health Medical Center - Hopewell, which includes two GE digital mammography units, two GE LOGIQ* E9 Ultrasound machines, and a 3Tesla Magnet for Breast MRI.”

*Trademark General Electric Company

About Capital Health:

Capital Health is the region’s leader in advanced medicine, with significant investments in innovative technologies and experienced physicians. Comprised of two hospitals in Mercer County and the Capital Health -Hamilton outpatient facility, Capital Health has three times received Magnet recognition for nursing excellence. Capital Health is a growing healthcare organization having just opened a new, state-of-the-art hospital in Hopewell Township, N.J. and completed a significant expansion of services at its Regional Medical Center in Trenton.


GE Healthcare provides transformational medical technologies and services that are shaping a new age of patient care. Our broad expertise in medical imaging and information technologies, medical diagnostics, patient monitoring systems, drug discovery, biopharmaceutical manufacturing technologies, performance improvement and performance solutions services help our customers to deliver better care to more people around the world at a lower cost. In addition, we partner with healthcare leaders, striving to leverage the global policy change necessary to implement a successful shift to sustainable healthcare systems.

Our “healthymagination” vision for the future invites the world to join us on our journey as we continuously develop innovations focused on reducing costs, increasing access and improving quality around the world. Headquartered in the United Kingdom, GE Healthcare is a unit of General Electric Company (NYSE: GE). Worldwide, GE Healthcare employees are committed to serving healthcare professionals and their patients in more than 100 countries. For more information about GE Healthcare, visit our website at

For our latest news, please visit

1 Rhodes D, Carrie B. Hruska, Stephan W. Phillips, Dana H. Whaley, and Michael K.O’connor, Dedicated Dual-Head Gamma Imaging for Breast Cancer Screening in Women with Mammographically Dense Breasts, Radiology 100625; Published online November 2, 2010, doi 10.1148/radiol.10100625


Rebecca Hayne
[email protected]

KEYWORDS:   United States  North America  New Jersey  Wisconsin

INDUSTRY KEYWORDS:   Women  Health  Hospitals  Medical Devices  Oncology  Consumer  General Health